CSF3 and graft versus host disease: The effect of G‐CSF administration on grades II–IV acute GVHD was significant based on recipient age following BMT (p for interaction = .009), conditioning regimen following PBSCT (p for interaction = .038), and GVHD prophylaxis following CBT (p for interaction = .024).